Bajaj Healthcare Promoter Converts 4,55,074 Warrants to Equity Shares
Sajankumar Rameshwarlal Bajaj, promoter of Bajaj Healthcare Limited, converted 4,55,074 convertible warrants into equity shares on 18th March 2026. His shareholding increased from 1,18,70,700 shares (37.59%) to 1,23,25,774 shares (36.62%). The conversion expanded the company's total equity capital from 3,15,83,252 shares to 3,36,62,661 shares, each with Rs. 5 face value. The disclosure was made under SEBI regulations for substantial acquisition of shares.

*this image is generated using AI for illustrative purposes only.
Bajaj Healthcare promoter Sajankumar Rameshwarlal Bajaj has converted 4,55,074 convertible warrants into equity shares, as disclosed in a regulatory filing under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The conversion took place on 18th March 2026, resulting in the allotment of an equivalent number of equity shares.
Shareholding Changes
The warrant conversion has altered the promoter's shareholding structure in the company. Prior to the conversion, Sajankumar Rameshwarlal Bajaj held 1,18,70,700 equity shares representing 37.59% of the total share capital. Additionally, he held 4,55,074 convertible warrants, bringing his total holding to 1,23,25,774 shares or 39.03% on a diluted basis.
| Parameter | Before Conversion | After Conversion |
|---|---|---|
| Equity Shares Held | 1,18,70,700 | 1,23,25,774 |
| Shareholding % | 37.59% | 36.62% |
| Convertible Warrants | 4,55,074 | - |
| Total Holding % (Diluted) | 39.03% | 36.62% |
Impact on Share Capital
The conversion has expanded Bajaj Healthcare Limited's total equity share capital. The company's equity base increased from 3,15,83,252 shares to 3,36,62,661 shares, each carrying a face value of Rs. 5. This expansion represents the conversion of all outstanding warrants held by the promoter.
| Share Capital Details | Before | After |
|---|---|---|
| Total Equity Shares | 3,15,83,252 | 3,36,62,661 |
| Face Value per Share | Rs. 5 | Rs. 5 |
| Total Share Capital Value | Rs. 15,79,16,260 | Rs. 16,83,13,305 |
Regulatory Compliance
The disclosure was made by Sajankumar Rameshwarlal Bajaj in his capacity as Chairman and Managing Director of the company. As a promoter, he is required to disclose substantial changes in shareholding under Regulation 29(1) of SEBI regulations. The company's shares are listed on both BSE Limited and National Stock Exchange of India Limited.
Transaction Details
The warrant conversion represents a straightforward corporate action where existing convertible securities were exercised into equity shares. The mode of acquisition was through allotment of equity shares pursuant to the conversion of convertible warrants. No encumbrances, pledges, or liens were reported on the shares before or after the conversion.
Historical Stock Returns for Bajaj HealthCare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.53% | -1.23% | -5.95% | -35.43% | -53.92% | -14.58% |
How might the increased share capital and dilution affect Bajaj Healthcare's earnings per share and dividend distribution in upcoming quarters?
Will the promoter consider further equity infusion or warrant issuances to fund the company's expansion plans following this conversion?
What impact could the reduced promoter shareholding percentage have on institutional investor interest and stock liquidity?


































